FindTrial
Sign In

The efficacy of topical mometasone furoate for treating severe phimosis: a comparison of two treatment regimens

The efficacy of topical mometasone furoate for treating severe phimosis: a comparison of two treatment regimens

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100050526
Enrollment
Unknown
Registered
2021-08-28
Start date
2021-09-10
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

phimosis

Interventions

Experimental group2:twice a day of steroid therapy
Experimental group1:once a day of steroid therapy

Sponsors

Shenzhen Children’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
No minimum to 16 Years

Inclusion criteria

Inclusion criteria: Severe physical phimosis in all children.

Exclusion criteria

Exclusion criteria: 1. Secondary or pathological phimosis; 2. Those who have not completed the course of medication and follow-up; 3. Those who have recently used local or systemic glucocorticoids, etc.

Design outcomes

Primary

MeasureTime frame
Turn up the foreskin to expose the glans;—

Countries

China

Contacts

Public ContactZhou Guanglun

Shenzhen Children's Hospital

z72602017@126.com+86 18938690712

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026